"Recent studies have shown that ZEB1 expression is correlated with high (n = ???8) Gleason grade prostate adenocarcinomas, indicating that ZEB1 is a marker of an aggressive prostate cancer phenotype in patients (Graham et al., 2008 )." . . . .